Learn about single-hand placement with a built-in loading tip

GO NOW

The most effective hormone-free birth control1*

Paragard® IUS is >99% Effective1

Percentage of women who will not become pregnant within 1 year (typical use)‡

 
Over 99% effective
91% - 99% effective
74% - 90% effective
Less than 73% effective
 
Hormone Free Paragard
Hormone-Free Paragard
Hormonal IUS
Hormonal IUS
Hormonal Implant
Hormonal Implant
Sterilization
Sterilization
Injection
Injection
Pill
Pill
Patch
Patch
Ring
Ring
Diaphragm
Diaphragm
Condoms
Condoms
Withdrawal
Withdrawal
Sponge
Sponge
Spermicide
Spermicide
Fertility awareness based methods
Fertility awareness-based methods
No birth control method
No birth control method
Paragard IUD
Hormone-Free Paragard
Sterilization
Sterilization
Diaphragm
Diaphragm
Condoms
Condoms
Withdrawal
Withdrawal
Sponge
Sponge
Spermicide
Spermicide
Fertility awareness-based methods
Fertility awareness-based methods
No birth control method
No birth control method
Paragard IUD
Hormone-Free Paragard
Hormonal IUS
Hormonal IUS
Hormonal Implant
Hormonal Implant
Injection
Injection
Pill
Pill
Patch
Patch
Ring
Ring

ALL BIRTH CONTROL METHODS

Over 99% effective

91% – 99% effective

74% – 90% effective

Less than 73% effective

HORMONE FREE METHODS

Over 99% effective

74% – 99% effective

Less than 73% effective

HORMONAL METHODS

Over 99% effective

91% – 99% effective

Trussell J. Contraceptive failure in the United States. Contraception 2011 May;83(5):397-404.

Paragard does not protect against HIV/AIDS or other sexually transmitted infections.

INDICATIONS AND USAGE

Paragard is a copper-containing intrauterine system (IUS) indicated for prevention of pregnancy in females of reproductive potential for up to 10 years.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

  • The use of Paragard is contraindicated when one or more of the following conditions exist:
    • Pregnancy or suspicion of pregnancy, abnormalities of the uterus resulting in distortion of the uterine cavity, acute pelvic inflammatory disease (PID), postpartum or postabortal endometritis in the past 3 months, known or suspected uterine or cervical malignancy, uterine bleeding of unknown etiology, untreated acute cervicitis or vaginitis or other lower genital tract infection, conditions associated with increased susceptibility to pelvic infections, Wilson’s disease, a previously placed IUS that has not been removed, hypersensitivity to any component of Paragard including to copper or any of the trace elements present in the copper component of Paragard.

INDICATIONS AND USAGE

Paragard is a copper-containing intrauterine system (IUS) indicated for prevention of pregnancy in females of reproductive potential for up to 10 years.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

  • The use of Paragard is contraindicated when one or more of the following conditions exist:
    • Pregnancy or suspicion of pregnancy, abnormalities of the uterus resulting in distortion of the uterine cavity, acute pelvic inflammatory disease (PID), postpartum or postabortal endometritis in the past 3 months, known or suspected uterine or cervical malignancy, uterine bleeding of unknown etiology, untreated acute cervicitis or vaginitis or other lower genital tract infection, conditions associated with increased susceptibility to pelvic infections, Wilson’s disease, a previously placed IUS that has not been removed, hypersensitivity to any component of Paragard including to copper or any of the trace elements present in the copper component of Paragard.

WARNINGS AND PRECAUTIONS

  • Ectopic Pregnancy: Evaluate for possible ectopic pregnancy in any female who becomes pregnant while using Paragard.
  • Intrauterine Pregnancy: Failure to remove Paragard increases the risk of miscarriage, sepsis, premature labor, and premature delivery.
  • Sepsis: Severe infection or sepsis, including Group A Streptococcal Sepsis (GAS), have been reported following insertion of IUSs, including Paragard.
  • Pelvic Inflammatory Disease and Endometritis: Remove Paragard in cases of recurrent PID or endometritis, or if an acute pelvic infection is severe or does not respond to treatment.
  • Embedment: Partial penetration or embedment of Paragard in the myometrium can make removal difficult; surgical removal may be necessary. Breakage of an embedded Paragard during non-surgical removal has been reported.
  • Perforation: Partial or total perforation of the uterine wall or cervix may reduce contraceptive efficacy and result in pregnancy. Delayed detection or removal of Paragard may result in migration outside the uterine cavity, adhesions, peritonitis, intestinal penetration, intestinal obstruction, abscesses and/or damage to adjacent organs. Increased risk when the uterus is fixed, retroverted or not completely involuted during the postpartum period. If perforation does occur, locate and remove Paragard promptly.
  • Expulsion: Partial or complete expulsion of Paragard has been reported, resulting in the loss of contraceptive protection. The risk of expulsion may be increased when the uterus is not completely involuted at the time of insertion. Remove a partially expelled Paragard.
  • Wilson’s Disease: Paragard may exacerbate Wilson’s disease.
  • Bleeding Pattern Alterations: Paragard can alter the bleeding pattern and result in heavier and longer menstrual cycles with intermenstrual spotting.
  • Magnetic Resonance Imaging (MRI) Safety Information: Non-clinical testing has demonstrated that Paragard is MR Conditional.
  • Medical Diathermy: Avoid using high medical RF transmitter devices in females with Paragard.

ADVERSE REACTIONS

  • Adverse reactions reported in clinical trials include anemia, backache, dysmenorrhea, dyspareunia, expulsion (complete or partial), prolonged menstrual flow, menstrual spotting, pain and cramping, and vaginitis.

INDICATIONS AND USAGE

Paragard is a copper-containing intrauterine system (IUS) indicated for prevention of pregnancy in females of reproductive potential for up to 10 years.

Please see full Prescribing Information.

Reference:

1. Trussell J. Contraceptive failure in the United States.  Contraception 2011 May;83(5):397-404.

*Excluding sterilization.

‡Among typical couples who initiate use of a method (not necessarily for the first time), the percentage who will not experience an accidental pregnancy during the first year if they do not stop use for any other reason.